Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Tyra Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +5 vs. Q4 2022
- Shares held
- 35.7M
- +414.5K (+1.2%) vs. Q4 2022
- Total value
- $573.0M
- +$305.1M (+113.9%) vs. Q4 2022
- New holders
- 10
- 16 more added
- Sold out
- 5
- 10 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,236,454 | $116.3M | 2.63% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $103.6M | 5.09% | 00.0% | Unchanged |
| Canaan Partners XI LLC | 4,409,991 | $70.9M | 50.98% | 00.0% | Unchanged |
| BVF Inc | 3,239,595 | $52.1M | 1.90% | +767,268+31.0% | Added |
| FMR LLC | 3,147,987 | $50.6M | 0.00% | −731,136−18.8% | Reduced |
| Nextech Invest AG | 2,518,582 | $40.5M | 16.89% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 1,989,103 | $32.0M | 6.23% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,421,310 | $22.8M | 1.65% | +93,645+7.1% | Added |
| Fairmount Funds Management LLC | 1,416,998 | $22.8M | 3.92% | 00.0% | Unchanged |
| BlackRock Inc. | 666,885 | $10.7M | 0.00% | +11,794+1.8% | Added |
| Vanguard Group Inc | 639,324 | $10.3M | 0.00% | +34,957+5.8% | Added |
| Perceptive Advisors LLC | 494,403 | $7.95M | 0.24% | 00.0% | Unchanged |
| Woodline Partners LP | 410,435 | $6.60M | 0.09% | +111,419+37.3% | Added |
| Geode Capital Management, LLC | 286,104 | $4.60M | 0.00% | +32,412+12.8% | Added |
| State Street Corp | 232,089 | $3.73M | 0.00% | +15,463+7.1% | Added |
| JPMorgan Chase & Co | 192,509 | $3.09M | 0.00% | −6,698−3.4% | Reduced |
| Driehaus Capital Management LLC | 134,173 | $2.16M | 0.03% | +134,173 | New |
| Northern Trust Corp | 107,542 | $1.73M | 0.00% | +1,775+1.7% | Added |
| Charles Schwab Investment Management Inc | 102,370 | $1.65M | 0.00% | +3,867+3.9% | Added |
| Logos Global Management LP | 87,673 | $1.41M | 0.20% | −23,183−20.9% | Reduced |
| Wellington Management Group LLP | 84,260 | $1.35M | 0.00% | +6,105+7.8% | Added |
| Ikarian Capital, LLC | 48,170 | $774.1K | 0.32% | +48,170 | New |
| Artia Global Partners LP | 45,253 | $727.2K | 0.29% | +45,253 | New |
| Bank of New York Mellon Corp | 41,531 | $667.4K | 0.00% | −4,838−10.4% | Reduced |
| Victory Capital Management Inc | 33,760 | $542.5K | 0.00% | +33,760 | New |
| Fishman Jay A Ltd | 22,000 | $353.5K | 0.05% | 00.0% | Unchanged |
| Rhumbline Advisers | 21,926 | $352.0K | 0.00% | +1,178+5.7% | Added |
| Mariner, LLC | 21,529 | $346.0K | 0.00% | +21,529 | New |
| LPL Financial LLC | 19,500 | $313.4K | 0.00% | −500−2.5% | Reduced |
| Nuveen Asset Management, LLC | 18,756 | $301.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 18,011 | $289.4K | 0.00% | −2,951−14.1% | Reduced |
| Morgan Stanley | 15,309 | $246.0K | 0.00% | +4,906+47.2% | Added |
| Millennium Management LLC | 13,475 | $217.0K | 0.00% | +13,475 | New |
| Sepio Capital, LP | 10,625 | $170.7K | 0.02% | 00.0% | Unchanged |
| New York State Common Retirement Fund | 10,525 | $169.1K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 8,138 | $130.8K | 0.00% | +3,127+62.4% | Added |
| MetLife Investment Management | 7,702 | $123.8K | 0.00% | +7,702 | New |
| Barclays PLC | 6,785 | $109.0K | 0.00% | +3,204+89.5% | Added |
| American International Group, Inc. | 6,400 | $102.8K | 0.00% | +127+2.0% | Added |
| California State Teachers Retirement System | 4,930 | $79.2K | 0.00% | −592−10.7% | Reduced |
| UBS Group AG | 4,619 | $74.2K | 0.00% | +1,032+28.8% | Added |
| Wells Fargo & Company | 2,362 | $38.0K | 0.00% | +2,362 | New |
| Tower Research Capital LLC (TRC) | 1,546 | $25.0K | 0.00% | −347−18.3% | Reduced |
| Legal & General Group Plc | 1,405 | $22.6K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 1,325 | $21.0K | 0.00% | −296−18.3% | Reduced |
| Ameritas Investment Partners, Inc. | 940 | $15.1K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 814 | $13.1K | 0.00% | +814 | New |
| Royal Bank of Canada | 742 | $12.0K | 0.00% | −2,602−77.8% | Reduced |
| The PNC Financial Services Group, Inc. | 58 | $932 | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 54 | $868 | 0.00% | +54 | New |
| Nisa Investment Advisors, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −152,159−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −33,005−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −26,717−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −89−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1−100.0% | Sold out |